Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Chevron Corporation (CVX): Three Things to Know Before You Buy Stock

As one of our largest oil companies, Chevron Corporation (NYSE:CVX) is a company you’ve probably heard of before. In fact, given what you’re paying at the pump these days, and all the talk about oil and natural gas, you just might be thinking about buying a few shares of its stock. Before you make that purchase, there are three core areas to its business performance that you need to know a little more about.

Production growth
Topping the list is Chevron Corporation (NYSE:CVX)’s ambitious plan to grow its oil and gas production by 1 million barrels of oil equivalent per day, or MMBOED, by 2017. That would put the company’s overall total daily production of 3.3 MMBOE in 2017. That’s an ambitious goal, but it would still be a far cry from Exxon Mobil Corporation (NYSE:XOM) overall projected production of 4.8 MMBOED by that time. What is different is the rate of growth.

Exxon Mobil Corporation (NYSE:XOM), for example, expects to add only 600,000 BOED of production over that time frame, which equates to a growth rate of 2%-3% annually. Production growth is really hard to come by as oil companies are fighting an uphill battle against the natural decline of an oil and gas well. Even smaller exploration and production companies such as ConocoPhillips (NYSE:COP) need to spend billions of dollars just to grow production by 3%-5% each year. With that context, Chevron Corporation (NYSE:CVX)’s doing a really great job at growing its production, especially relative to its peers.

Return on capital
That being said, is this a growth at all costs company? Last year, Chevron Corporation (NYSE:CVX) earned 18.7% on the capital it employed to grow its business. That’s a terrific number, but it’s not the highest-returning major oil company. That honor goes to ExxonMobil, which enjoyed a return on capital employed of nearly 25%.

However, when you look at other oil majors such as BP plc (ADR) (NYSE:BP) and Royal Dutch Shell plc (ADR) (NYSE:RDS.A) you can see that Chevron Corporation (NYSE:CVX) really does shine. Last year BP plc (ADR) (NYSE:BP)’s return on capital employed was under 10%, while Shell’s was just slightly over 10%. Again, with that as context, Chevron really stands out as company that delivers not just growth, but profitable growth.

Shareholder returns
Growth is nice, but does it translate into shareholder returns? That’s the only reason you’d be buying its stock, so a history of returns something you’ll want to see. Again, the news here is good, as Chevron’s stock has vastly outperformed its peers:

Source: Chevron investor presentation.

Not only that, but just last year the company increased its dividend by 11% and bought back $5 billion in its own stock. Given the company’s projected future production growth and the returns that growth should generate, it’s fairly safe to say that investors should do well over the next few years.

The article 3 Things to Know Before You Buy Stock in Chevron originally appeared on Fool.com and is written by Matt DiLallo.

Fool contributor Matt DiLallo owns shares of ConocoPhillips. The Motley Fool recommends Chevron and Total.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!